BD expands biosciences business with reagent innovation center in San Diego

By Sean Whooley | November 22, 2021

BD Biosciences Breakthrough Torrey View San Diego

[Image from Breakthrough]

A life sciences real estate developer announced today that BD (NYSE:BDX) selected its property as a new facility for its biosciences business.

Through a joint venture with Tishman Speyer and Bellco Capital, Breakthrough Properties confirmed that BD chose its Torrey View by Breakthrough property for an expanded San Diego reagent innovation center within its biosciences segment.

Get the full story at our sister site, MassDevice.

Filed Under: Drug Discovery, RD
Tagged With: BD

About The Author

Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.